Requests that the FDA determine and declare that Tolmetin Capsules 150 mg and 300 mg is suitable for submission in an Abbreviated New Drug Application (ANDA)
FDA-2026-P-7180
Documents
6
Total comments
0
all analyzed
Comment status
Open
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
📄 Primary document
- Other· Jun 29, 2026No comment period
- Supporting & Related Material· Jun 29, 2026
- Supporting & Related Material· Jun 29, 2026
- Supporting & Related Material· Jun 29, 2026